Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,719 | -24,179 | -92,189 | -71,427 | -49,406 |
| Depreciation Amortization | 3,903 | 2,001 | 9,613 | 7,563 | 5,491 |
| Accounts receivable | 5,987 | 4,981 | -2,012 | 2,524 | 1,896 |
| Accounts payable and accrued liabilities | -4,765 | -942 | 764 | 432 | -1,944 |
| Other Working Capital | -817 | -1,706 | -6,026 | 908 | 3,869 |
| Other Operating Activity | 9,141 | 1,072 | 22,332 | 12,682 | 10,614 |
| Operating Cash Flow | $-33,270 | $-18,773 | $-67,518 | $-47,318 | $-29,480 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,142 | -7,405 | 8,843 | -2,858 | -11,008 |
| PPE Investments | -1,700 | -344 | -10,392 | -9,371 | -6,104 |
| Investing Cash Flow | $4,442 | $-7,749 | $-1,549 | $-12,229 | $-17,112 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -4,500 | N/A | N/A |
| Common Stock Issued | 35,379 | 35,473 | 73,309 | 73,213 | 70,805 |
| Other Financing Activity | 0 | 0 | 0 | -4,500 | -4,500 |
| Financing Cash Flow | $35,379 | $35,473 | $68,809 | $68,713 | $66,305 |
| Beginning Cash Position | 21,007 | 21,007 | 21,265 | 16,765 | 21,265 |
| End Cash Position | 27,558 | 29,958 | 21,007 | 25,931 | 40,978 |
| Net Cash Flow | $6,551 | $8,951 | $-258 | $9,166 | $19,713 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,270 | -18,773 | -67,518 | -47,318 | -29,480 |
| Capital Expenditure | -1,700 | -344 | -10,433 | -9,373 | -6,116 |
| Free Cash Flow | -34,970 | -19,117 | -77,951 | -56,691 | -35,596 |